Extended-spectrum beta-lactamaseproducing bacteria in a Tertiary Care Hospital in Madrid: Epidemiology, risk factors and antimicrobial susceptibility patterns

Emerging Health Threats Journal

Volumn 5, Issue 1, 2012, Pages

  Rubio Perez, Ines ^a   Martin Perez, Elena ^a   Garcia, Diego Domingo ^a   Calvo, Manuel Lopez Brea ^a   Barrera, Eduardo Larrañaga ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

Antimicrobial resistance; Enterobacteriaceae; ESBL; Extended spectrum beta lactamases; Institutional epidemiology; Nosocomial infection

Indexed keywords

CARBAPENEM DERIVATIVE; EXTENDED SPECTRUM BETA LACTAMASE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; ENTEROBACTER AEROGENES; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; FEMALE; HUMAN; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PROTEUS VULGARIS; RISK FACTOR; SPAIN; TERTIARY HEALTH CARE;

EID: 84869784271     PISSN: None     EISSN: 17528550     Source Type: Journal    
DOI: 10.3402/ehtj.v5i0.11589     Document Type: Article

References (26)

1. Gómez J, García Vázquez E, Ruiz Gómez J. Clinical relevance of bacterial resistance: a historical approach (1982-2007). Rev Esp Quimioter. 2008;21:115-22.
2. Rodríguez-Baño J, López-Cerero L, Navarro MD, Díaz de Alba P, Pascual A. Faecal carriage of extended-spectrum betalactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology. J Antimicrob Chemother. 2008;62:1142-9.
3. Graffunder EM, Preston KE, Evans AM, Venezia R. Risk factors associated with extended-spectrum b-lactamaseproducing organisms at a tertiary care hospital. J Antimicrob Chemother. 2005;56:139-45.
4. Livermore DM, Canton R, Gniadkowski M, Nordmann P, Rossolini GM, Arlet G, et al. CTX-M: changing the face of ESBLs in Europe. J Antimicrob Chemother. 2007;59:165-70.
5. Coque TM, Baquero F, Canton R. Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Euro Surveill. 2008;13. pii: 19044.
6. Rodríguez-Baño J, Alcalá J, Cisneros JM, Grill F, Oliver A, Horcajada JP, et al. Escherichia coli producing SHV-type extended-spectrum beta-lactamase is a significant cause of community-acquired infection. J Antimicrob Chemother. 2009;63:781-4.
7. Denholm JT, Huysmans M, Spelman D. Community acquisition of ESBL-producing Escherichia coli: a growing concern. Med J Aust. 2009;190:45-6.
8. Owens RC, Rice L. Hospital-based strategies for combating resistance. Clin Infect Dis. 2006;42:173-81.
9. Howard DP, Williams C, Sen S, Shah A, Daurka J, Bird R, et al. A simple effective clean practice protocol significantly improves hand decontamination and infection control measures in the acute surgical setting. Infection. 2009;37:34-8.
10. Hernández JR, Martínez-Martínez L, Cantón R, Coque TM, Pascual A; Spanish Group for Nosocomial Infections (GEIH). Nationwide study of Escherichia coli and Klebsiella pneumoniae producing extended-spectrum beta-lactamases in Spain. Antimicrob Agents Chemother. 2005;49:2122-5.
11. Guembe M, Cercenado E, Alcalá L, Marín M, Insa R, Bouza E. Evolution of antimicrobial susceptibility patterns of aerobic and facultative gram-negative bacilli causing intra-abdominal infections: results from the SMART studies 2003-2007. Rev Esp Quimioter. 2008;21:166-73.
12. Rossi F, Baquero F, Hsueh PR, Paterson DL, Bochicchio GV, Snyder TA, et al. In vitro susceptibilities of aerobic and facultatively anaerobic gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends). J Antimicrob Chemother. 2006;58:205-10.
13. Baquero F, Cercenado E, Cisterna R, De la Rosa M, García-Rodríguez JA, Gobernado M, et al. Patrones de sensibilidad a antimicrobianos de Enterobacteriaceae causantes de infecciones intraabdominales en España: resultados del estudio SMART 2003. Rev Esp Quimioter. 2006;19:51-9.
14. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 20th informational supplement. M100-S20 CLSI. Wayne, PA: Clinical and Laboratory Standards Institute; 2010.
15. MacKenzie FM, Miller CA, Gould IM. Comparison of screening methods for TEM and SHV-derived extended-spectrum beta-lactamase detection. Clin Microbiol Infect. 2002;8: 715-24.
16. Drieux L, Brossier F, Sougakoff W, Jarlier V. Phenotypic detection of extended-spectrum betalactamase production in Enterobacteriaceae: review and bench guide. Clin Microbiol Infect. 2008;14:90-103.
17. Wroblewska MM, Rudnicka J, Marchel H, Luczak M. Multidrug-resistant bacteria isolated from patients hospitalised in Intensive Care Units. Int J Antimicrob Agents. 2006;27: 285-9.
18. Mulvey MR, Bryce E, Boyd D, Ofner-Agostini M, Christianson S, Simor AE, et al. Ambler class A extended-spectrum B-lactamase producing Escherichia coli and Klebsiella spp. in Canadian hospitals. Antimicrob Agents Chemother. 2003; 48:1204-14.
19. Kaye KS, Schmader KE, Sawyer R. Surgical site infection in the elderly population. Clin Infect Dis. 2004;39:1835-41.
20. Kamboj M, Sepkowitz KA. Nosocomial infections in patients with cancer. Lancet Oncol. 2009;10:589-97.
21. Saint S, Savel RH, Matthay MA. Enhancing the safety of critically ill patients by reducing urinary and central venous catheter-related infections. Am J Respir Crit Care Med. 2002;165:1475-9.
22. Paterson DL, Ku WC, von Guttberg A, Mohapatra S, Casellas JM, Goossens H, et al. Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extendedspectrum b-lactamases. Clin Infect Dis. 2003;39:31-7.
23. Bowler PG, Duerden BI, Armstrong DG. Wound microbiology and associated approaches to wound management. Clin Microbiol. 2001;14:244-69.
24. Owens CD, Stoessel K. Surgical site infections: epidemiology, microbiology and prevention. J Hosp Infect. 2008;70:3-10.
25. Queenan AM, Foleno B, Gownley C, Wira E, Bush K. Effects of inoculum and beta-lactamase activity in AmpC- and extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae clinical isolates tested by using NCCLS ESBL methodology. J Clin Microbiol. 2004;42:269-75.
26. Treviño M, Moldes L, Martínez-Lamas L, Varón C, Regueiro BJ. Carbapenem-resistant Enterobacter cloacae and the emergence of metallo-beta-lactamase-producing strains in a thirdlevel hospital (Santiago de Compostela, NW Spain). Eur J Clin Microbiol Infect Dis. 2009;28:1253-8.